Pharmaceutical News

RSS

Scientists identify causative factor behind lung edema

New research has found that in cases of lung edema, or fluid in the lungs, not only do the lungs fail to keep water out as previously believed, but they are also allowing water to pump in.

7 May 2013

34% of all adverts for antidepressants are misleading by industry's self-regulation system

The new feature of the antidepressant drugs of the 1990s was that they had milder side-effects than their predecessors. Combined with aggressive marketing, this meant that annual sales in Sweden increased from just under EUR 18 million to over EUR 100 million in the space of just a few years.

6 May 2013

Australia approves Fziomed’s new viscoelastic gel

FzioMed, a privately held medical device company based in San Luis Obispo, CA., is pleased to announce the inclusion of Dynavisc on the Australian Register of Therapeutic Goods (ARTG).

From Medtronic 6 May 2013

Pharmapendium adds new module to benefit researchers and toxicologists

Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announces that PharmaPendium, the leading source of preclinical, clinical and post-market data, has added a new module to its content base, the Metabolizing Enzymes and Transporters Module.

6 May 2013

Oral drops provide a safe and effective alternative for allergy sufferers

Allergy shots are commonly used to treat children with severe environmental allergies and asthma, but under-the-tongue drops may offer yet another beneficial - and stick-free - option for pediatric allergy sufferers, according to a Johns Hopkins Children's Center review of existing scientific evidence.

6 May 2013

Scioderm gets Breakthrough Therapy designation for SD-101 from FDA for treatment of EB

Scioderm announced its investigational product SD-101 has received Breakthrough Therapy designation by the U.S. Food and Drug Administration for the treatment of patients with inherited Epidermolysis Bullosa.

5 May 2013

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved LIPTRUZET (ezetimibe and atorvastatin) tablets for the treatment of elevated low-density lipoprotein cholesterol in patients with primary or mixed hyperlipidemia as adjunctive therapy to diet when diet alone is not enough.

4 May 2013

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved a supplemental new drug application for SUSTIVA (efavirenz), including dosing recommendations for HIV-1 infected pediatric patients three months to three years old and weighing at least 3.5 kg.

4 May 2013

Vitamin C may decrease impact of smoking during pregnancy on childhood respiratory health

Pregnant women are advised not to smoke during pregnancy because it can harm the baby's lungs and lead to wheezing and asthma, among other problems. If a woman absolutely can't kick the habit, taking vitamin C during pregnancy may improve her newborn's lung function and prevent wheezing in the first year of life, according to a study to be presented Saturday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Washington, DC.

4 May 2013

Expert to explain how drugs induce damage to DNA in public lecture on May 16

Anticancer drugs save lives and/or improve the quality of life for many cancer patients. Many anti-cancer drugs work by killing tumor cells after inducing damage to DNA.

4 May 2013

Research finds no increased risk of abnormal heart rhythms despite FDA warning against citalopram

The U.S. Food and Drug Administration's warning that high doses of the antidepressant citalopram can cause potentially serious abnormal heart rhythms might be doing more harm than good.

4 May 2013

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

A team of researchers led by a Boston University Biomedical Engineer has developed a new joint lubricant that could bring longer lasting relief to millions of osteoarthritis sufferers.

3 May 2013

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Researchers at Johns Hopkins have identified a gene that, when repressed in tumor cells, puts a halt to cell growth and a range of processes needed for tumors to enlarge and spread to distant sites. The researchers hope that this so-called "master regulator" gene may be the key to developing a new treatment for tumors resistant to current drugs.

3 May 2013

Regeneron Pharmaceuticals expands ophthalmology portfolio

Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previously included in Regeneron's antibody collaboration with Sanofi.

3 May 2013

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of a variety of cancers, announced the issuance of a U.S. patent covering methods of treatment and formulations for its clinical-stage compound, 2-methoxyestradiol.

3 May 2013

With GPEI plan, polio eradication may finally be within reach

"After 25 years of remarkable achievements and sometimes harrowing setbacks, a successful conclusion to global polio eradication could finally be within reach," Nellie Bristol, a fellow with the Global Health Policy Center at the Center for Strategic and International Studies in Washington, D.C., and J. Stephen Morrison, senior vice president and director of the Global Health Policy Center at CSIS, write in a CSIS commentary.

3 May 2013

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Martindale Pharma, a leader in the manufacture and supply of specialty pharmaceuticals, is pleased to announce the UK launch of Prenoxad Injection, the world's first licensed emergency treatment for acute opioid related overdose for use at home or other non-medical settings.

3 May 2013

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

A study that aimed to understand how the cancer drug everolimus helps overcome the resistance breast cancers can develop to trastuzumab has left researchers contemplating a puzzle.

3 May 2013

Obama administration plans appeal of 'Plan B' ruling

The Obama administration signals that it will challenge a federal judge's order that would make an emergency contraception drug available over-the-counter to women of all ages. The move comes a day after the FDA said the contraception should be available in that way to anyone older than 15.

3 May 2013

High costs of cancer drugs may harm patients, say experts

The extremely high prices of recent cancer drugs "may be causing harm to patients," a large group of international leukemia experts warns.

3 May 2013

Pharmaceutical News

Scientists identify causative factor behind lung edema

34% of all adverts for antidepressants are misleading by industry's self-regulation system

Australia approves Fziomed’s new viscoelastic gel

Pharmapendium adds new module to benefit researchers and toxicologists

Oral drops provide a safe and effective alternative for allergy sufferers

Scioderm gets Breakthrough Therapy designation for SD-101 from FDA for treatment of EB

Merck's LIPTRUZET tablets get FDA approval for treatment of elevated LDL cholesterol

FDA approves sNDA for SUSTIVA for treatment of HIV-1 infected pediatric patients

Vitamin C may decrease impact of smoking during pregnancy on childhood respiratory health

Expert to explain how drugs induce damage to DNA in public lecture on May 16

Research finds no increased risk of abnormal heart rhythms despite FDA warning against citalopram

New joint lubricant brings longer lasting relief to osteoarthritis sufferers

Newly discovered ‘master regulator’ gene may help develop novel treatment for drug-resistant tumors

Regeneron Pharmaceuticals expands ophthalmology portfolio

EntreMed announces issuance of patent for clinical-stage compound, 2-methoxyestradiol

With GPEI plan, polio eradication may finally be within reach

Martindale Pharma announces UK launch of Prenoxad Injection for opioid overdose

Everolimus reverses trastuzumab resistance in early HER-2 positive breast cancer

Obama administration plans appeal of 'Plan B' ruling

High costs of cancer drugs may harm patients, say experts

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News